Epigenetic Biomarkers: Potential Applications in Gastrointestinal Cancers
Author(s) -
Jiaqiu Li,
Hongchuan Jin,
Xian Wang
Publication year - 2014
Publication title -
isrn gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 2090-4401
pISSN - 2090-4398
DOI - 10.1155/2014/464015
Subject(s) - epigenetics , dna methylation , histone , biology , cancer , cancer epigenetics , carcinogenesis , chromatin , chromatin remodeling , cancer research , computational biology , bioinformatics , medicine , genetics , dna , gene , gene expression , histone methyltransferase
Genetics and epigenetics coregulate the cancer initiation and progression. Epigenetic mechanisms include DNA methylation, histone modification, chromatin remodeling, and noncoding RNAs. Aberrant epigenetic modifications play a fundamental role in the formation of gastrointestinal cancers. Advances in epigenetics offer a better understanding of the carcinogenesis and provide new insights into the discovery of biomarkers for diagnosis, and prognosis prediction of human cancers. This review aims to overview the epigenetic aberrance and the clinical applications as biomarkers in gastrointestinal cancers mainly gastric cancer and colorectal cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom